Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

27.20
-0.2300-0.84%
Post-market: 27.200.00000.00%19:30 EDT
Volume:2.62M
Turnover:70.50M
Market Cap:3.43B
PE:-19.01
High:27.53
Open:27.01
Low:26.04
Close:27.43
52wk High:41.14
52wk Low:10.83
Shares:126.00M
Float Shares:110.00M
Volume Ratio:2.00
T/O Rate:2.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:14.33
PE(LYR):-17.77

Loading ...

Amylyx Says FDA Grants Avexitide Breakthrough Therapy, Orphan Drug Status for Post-Bariatric Hypoglycemia

Reuters
·
Aug 18

Amylyx announces Lucidity Phase 3 trial met primary endpoint

TIPRANKS
·
Aug 18

Amylyx Pharmaceuticals: Lucidity Met FDA-Agreed-upon Primary Endpoint and All Secondary Endpoints

THOMSON REUTERS
·
Aug 18

Amylyx: Plans to Submit Nda for Avexitide with FDA by Year-End & Plans for Potential Launch in 2027, if Approved

THOMSON REUTERS
·
Aug 18

Amylyx Pharmaceuticals, - Lucidity Meets All Secondary Endpoints with Significant Reductions in Hypoglycemic Events

THOMSON REUTERS
·
Aug 18

Amylyx Pharmaceuticals, - Avexitide Generally Well-Tolerated with Favorable Safety Profile

THOMSON REUTERS
·
Aug 18

NASDAQ Trade Halt Halt News Pending at 06:55 Am

Reuters
·
Aug 18

Amylyx Shares Gains Ahead of Drug Data Readout

Dow Jones
·
Aug 18

Amylyx up 17% after announcing expected results for Avexitide tomorrow

TIPRANKS
·
Aug 18

Amylyx to Release Phase 3 Lucidity Trial Topline Results for Avexitide in Post-Bariatric Hypoglycemia Aug. 18, 2026

Reuters
·
Aug 18

U.S. Research Roundup- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies

Reuters
·
Aug 17

Toronto Stock Exchange Hits Record High as Oil Prices Rise

TIPRANKS
·
Aug 13

Is Amylyx (AMLX) Quietly Rewriting Its R&D Risk‑Reward Profile As Losses Deepen Without Revenue?

Simply Wall St.
·
Aug 10

Amylyx Pharmaceuticals (AMLX) Could Be 5% Undervalued After Second Quarter Earnings

Simply Wall St.
·
Aug 08

Emera Inc. CEO on board with plans to boost energy infrastructure in Maritimes

Bloomberg
·
Aug 07

Amylyx Pharmaceuticals Readies for Pivotal LUCIDITY Data

TIPRANKS
·
Aug 07

Amylyx Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Earnings Flash (AMLX) Amylyx Pharmaceuticals Posts Q2 Loss $0.39 a Share, vs. FactSet Est of $0.35 Loss

MT Newswires Live
·
Aug 06

Amylyx Pharmaceuticals Q2 Posts Higher than Expected Loss

Reuters
·
Aug 06

Amylyx Q2 FY26 Net Loss Widens to $43.4 Million; SG&A Expenses Climb to $21.9 Million

Reuters
·
Aug 06